新华制药：LXH-1211片临床试验申请获批准

Core Viewpoint - Xinhua Pharmaceutical has received approval from the National Medical Products Administration for clinical trials of LXH-1211 tablets for the treatment of pulmonary arterial hypertension [1] Company Summary - Xinhua Pharmaceutical (000756.SZ) announced the receipt of the clinical trial approval notice for LXH-1211 tablets [1]